EXTRAORDINARY ELEVATION OF SERPINB2 GENE AFTER ANTI-CANCER DRUG TREATMENT IN BLADDER CANCER

被引：0
|
作者：
Hiraki, Miho
Arichi, Naoko
Kishi, Hirofumi
Anjiki, Haruki
Yasumoto, Hiroaki
Shiina, Hiroaki
机构：
来源：
JOURNAL OF UROLOGY | 2017年 / 197卷 / 04期
关键词：
D O I：
10.1016/j.juro.2017.02.1493
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP48-12
引用
收藏
页码：E641 / E641
页数：1
相关论文
共 50 条
  • [31] Valproic acid as anti-cancer drug
    Michaelis, Martin
    Doerr, Hans Wilhelm
    Cinatl, Jindrich, Jr.
    CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (33) : 3378 - 3393
  • [32] FTORAFUR - NEW ANTI-CANCER DRUG
    BRENNER, H
    CHAITCHIK, S
    BRENNER, J
    DIGESTION, 1977, 16 (03) : 233 - 233
  • [33] CISPLATIN - NEW ANTI-CANCER DRUG
    ROZENCWEIG, M
    ABELE, R
    BEDOGNI, P
    KENIS, Y
    LOUVAIN MEDICAL, 1979, 98 (10): : 679 - 684
  • [34] Mitosis as an anti-cancer drug target
    Salmela, Anna-Leena
    Kallio, Marko J.
    CHROMOSOMA, 2013, 122 (05) : 431 - 449
  • [35] The relevance of therapeutic drug monitoring in plasma and erythrocytes in anti-cancer drug treatment
    Dumez, H
    Guetens, G
    De Boeck, G
    Highley, MS
    Maes, RAA
    van Oosterom, AT
    de Bruijn, EA
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2004, 42 (11) : 1219 - 1227
  • [36] Optimal Anti-cancer Drug Profiles for Effective Penetration of the Anti-cancer Drug Market by Generic Drugs in Japan
    Shoyo Shibata
    Maiko Matsushita
    Yoshimasa Saito
    Takeshi Suzuki
    Therapeutic Innovation & Regulatory Science, 2018, 52 : 442 - 448
  • [37] Optimal Anti-cancer Drug Profiles for Effective Penetration of the Anti-cancer Drug Market by Generic Drugs in Japan
    Shibata, Shoyo
    Matsushita, Maiko
    Saito, Yoshimasa
    Suzuki, Takeshi
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2018, 52 (04) : 442 - 448
  • [38] Modulation of gene expression in the glandular and non-glandular regions of the rat stomach after treatment with the anti-cancer drug cisplatin
    Gale, D
    Blakemore, SJ
    Cook, T
    Kidwai, S
    Moore, I
    Moore, GB
    Moore, SE
    Sanger, GJ
    Liu, YL
    Malik, N
    Andrews, PL
    GASTROENTEROLOGY, 2005, 128 (04) : A545 - A545
  • [39] The risk of anti-cancer related cardiotoxicities in colorectal cancer patients following different anti-cancer drug treatments
    Wen, Pin-Chun
    Ciou, Wan-Jyun
    Ho, Chin-Chin
    Yang, Chen-Chang
    CLINICAL TOXICOLOGY, 2020, 58 (04) : 337 - 338
  • [40] PEG based anti-cancer drug conjugated prodrug micelles for the delivery of anti-cancer agents
    Senevirathne, Suchithra A.
    Washington, Katherine E.
    Biewer, Michael C.
    Stefan, Mihaela C.
    JOURNAL OF MATERIALS CHEMISTRY B, 2016, 4 (03) : 360 - 370
12345